Advanced search
Publication Cover
Journal of Contemporary East Asia Studies Volume 4, 2015 - Issue 1: Understanding Politics and Society in Modern China
Submit an article Journal homepage
671
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The Politics of Drug Price Control Policy in China: Regulation, Deregulation and Re-regulation

Sabirina LukCorrespondence[email protected]
View further author information
Pages 41-54 | Published online: 28 Mar 2017

  • The National People's Congress of the People's Republic of China, “Report on the Work of the Government,” (March 18, 2014), at <http://www.npc.gov.cn/englishnpc/Speeches/2014-03/18/content_1856703.htm> (search date: 12 May 2014).
  • Meng, Qingyue, Gang Cheng, Lynn Silver, Xiaojie Sun, Clas Rehnberg, and Göran Tomson, “The Impact of China's Retail Drug Price Control Policy on Hospital Expenditures: A Case Study in Two Shandong Hospitals,” Health Policy and Planning, 20–3 (May 2005):185.
  • Liang, Xue-feng, De-quanz Zheng, and Li-juan Yang, “The Dilemma of Drug Price Regulation and Countermeasures in China,” (2009), at http://www.umdcipe.org/conferences/policy_ex-changes/conf_papers/Papers/1401.PDF (search date: March 4, 2014).
  • Sun, Qiang, Michael A. Santoro, Qingyue Meng, Caitlin Liu, and Karen Eggleston, “Pharmaceutical Policy in China,” Health Affairs, 27–4 (July/August 2008):1045.
  • North, Douglass C., Institutions, Institutional Change and Economic Performance (Cambridge; New York: Cambridge University Press, 1990), 3.
  • Kingston, Christopher, “Institutions: Rules or Equilibria?,” in Norman Schofield and Gonzalo Caballero, eds., Political Economy of Institutions, Democracy and Voting (Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2011), 14.
  • Hall, Peter A, and Rosemary C.R. Taylor, “Political Science and the Three New Institutionalisms,” Political Studies, 44–5 (December 1996), 938.
  • Shih, Mei-chiang, Milan Tung-wen Sun, and Guang-xu Wang, “The Historical Institutionalism Analysis of Taiwan's Administrative Reform,” International Review of Administrative Sciences, 78 -2 (2012), 307.
  • (i) Thelen, Kathleen, and Sven Steinmo, “Historical Institutionalism in Comparative Politics,” in Sven Steinmo, Kathleen Thelen and Frank Longstreth, eds., Structuring Politics: Historical Institutionalism in Comparative Analysis (New York: Cambridge University Press,1992), 1–32.
  • Hall, Peter A, and Rosemary C.R. Taylor, op. cit., 938. (iii) Immergut, Ellen M., “The Theoretical Core of the New Institutionalism,” Politics & Society, 26–1 (March 1998), 5–34.
  • Thelen, Kathleen, “Beyond Comparative Statics: Historical Institutional Approaches to Stability and Change in the Political Economy of Labor,” in Glenn Morgan, John L. Campbell, Colin Crouch, Ove Kaj Pedersen, and Richard Whitley, eds., The Oxford Handbook of Comparative Institutional Analysis (Oxford; New York: Oxford University Press, 2010), 41–62.
  • (i) Thelen, Kathleen, and Sven Steinmo, op. cit., 1–32. (ii) Koelble, Thomas A., “The New Institutionalism in Political Science and Sociology,” Comparative Politics, 27–2 (January 1995), 231–243.(iii) Hall, Peter A, and Rosemary C.R. Taylor, op.cit., 936–957.
  • Kopstein, Jeffrey and Mark Lichbach, “The Framework of Analysis,” in Jeffrey Kopstein and Mark Lichbach, eds., Comparative Politics: Interests, Identities, and Institutions in a Changing Global Order (Third edition) (Cambridge; New York: Cambridge University Press, 2009), 23.
  • Ibid., 23.
  • Ibid., 23.
  • Dickson Clare, and Kent Buse, “Understanding the Politics of National HIV Policies: the Role of Institutions, Interests and Ideas,” (2008), at >www.hivpolicy.org/Library/HPP001555.pdf> (search date: 12 May 2014).
  • Alaszewski, Andy, and Patrick Brown, Making Health Policy: A Critical Introduction (Cambridge, UK: Polity, 2012), 208.
  • Galperin, Hernan, “Beyond Interests, Ideas, and Technology: An Institutional Approach to Communication and Information Policy,” The Information Society, 20–3 (2004), 161.
  • Béland, Daniel, and Alex Waddan, The Politics of Policy Change: Welfare, Medicare, and Social Security Reform in the United States (Washington, DC: Georgetown University Press, 2012), 8.
  • Galperin, Hernan, op. cit., 161.
  • (i) Campbell, John L., “Institutional Analysis and the Role of Ideas in Political Economy,” Theory and Society, 27–3 (June 1998), 380–381. (ii) Campbell, John L., “Ideas, Politics, and Public Policy,” Annual Review of Sociology, 28 (2002), 26–7.
  • Cortell, Andrew P., and Susan Peterson, “Altered States: Explaining Domestic Institutional Change,” British Journal of Political Science, 29–1 (January 1999), 189.
  • Béland, Daniel, and Alex Waddan, op. cit., 8.
  • (i) Yin, Robert K, Case Study Research: Design and Methods (Third edition) (Thousand Oaks, Calif.: Sage Publications, 2003), 1. (ii) Thomas, Gary, How to Do Your Case Study: A Guide for Students and Researchers (Los Angeles, Calif.; London: SAGE, 2011), 4.
  • Denscombe, Martyn, The Good Research Guide: For Small-scale Social Research Projects (Second edition) (Maidenhead, Berkshire: Open University Press, 2003), 38.
  • David, Matthew, “Editor's Introduction,” in Matthew David, ed., Case Study Research. Volume I., (London; Thousand Oaks, Calif: SAGE, 2006), XXVI.
  • Stoecker, Randy, “Evaluating and Rethinking the Case Study,” in Matthew David, ed., Case Study Research (Volume IV) (London; Thousand Oaks, Calif.: SAGE, 2006), 330.
  • Thomas, Gary, op.cit., 4.
  • Ibid., 4.
  • Denscombe, Martyn, op.cit.,38.
  • Denzin, Norman K., and Yvonna S. Lincoln, “Introduction: The Discipline and Practice of Qualitative Research,” in Norman K. Denzin and Yvonna S. Lincoln, eds., Handbook of Qualitative Research (Second edition) (Thousand Oaks: Sage Publications, 2000), 5.
  • (i) Townsend, James R, and Brantly Womack, Politics in China (Third edition) (Boston: Little, Brown and Company, 1986). (ii) Gu, Sharron, Law and Politics in Modern China: under the Law, the Law, and above the Law (Amherst, NY: Cambria Press, 2009). (iii) Guo, Xiaoqin, State and Society in China's Democratic Transition: Confucianism, Leninism, and Economic Development (New York: Routledge, 2003). (iv) Duckett, Jane, The Chinese State's Retreat from Health: Policy and the Politics of Retrenchment (Abingdon, Oxon: New York: Routledge, 2011).
  • Li, Cheng, “China's Communist Party-state: The Structure and Dynamics of Power,” in William A. Joseph, ed., Politics in China: an Introduction (Oxford; New York: Oxford University Press, 2010), 166.
  • (i) Gu, Sharron, op. cit., 132. (ii) Duckett, Jane, op. cit., 14.
  • Saich, Tony, Governance and Politics of China (Second edition) (Basingstoke, Hampshire [UK]; New York: Palgrave Macmillan, 2004), 28.
  • Cheng, Joseph Yu-shek, and Franklin Wankun Zhang, “Chinese Foreign Relation Strategies Under Mao and Deng: A Systematic and Comparative Analysis,” Kasarinlan: Philippine Journal of Third World Studies, 14–3 (1999), 96.
  • Saich, Tony, op. cit., 28.
  • Liou, Kuotsai Tom, Managing Economic Reforms in Post-Mao China (Westport, Conn.: Greenwood, 1998), 9.
  • Tisdell, Clem, “Economic Reform and Openness in China: China's Development Policies in the Last 30 Years,” Economic Analysis & Policy, 39–2 (September 2009), 272.
  • Huang Yanfen, and Yiyong Yang, “Pharmaceutical Pricing in China,” in Karen Eggleston, ed., Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific (The Walter H. Shorenstein Asia-Pacific Research Center, 2009), 206.
  • Dong, Hengjin, Lennart Bogg, clas Rehnberg, and Vinod Diwan, “Drug Policy in China: Pharmaceutical Distribution in Rural Areas,” Social Science & Medicine, 48–6 (March 1999), 782.
  • Zhou, Xue-rong, Zhonghuo yiliao iiage de zhengfu guanzhi yanjiu [The Study of Government Regulating Medicine Prices in China] (China: China Social Sciences Press, 2008), 121.
  • (i) Grogan, Colleen M., “Urban Economic Reform and Access to Health Care Coverage in the People's Republic of China,” Social Science and Medicine, 41–8 (October 1995), 1073–1084.
  • Cheung, Anthony, “Health Policy Reform,” in Linda Wong and Norman Flynn, eds., The Market in Chinese Social Policy (Houndmills, Basingstoke, Hampshire; New York: Palgrave, 2001), 63–87.
  • Liu, Gordan G., Peter Yuen, The-wei Hu, Ling Li, Xingzhu Liu, “Urban Health Insurance Reform: What Can We Learn from the Pilot Experiments?” in Aimin Chen, Gordon G. Liu, and Kevin H. Zhang, eds., Urbanization and Social Welfare in China (Aldershot, Hants, England; Burlington, VT: Ashgate, 2004), 38–62.
  • Yu, Xuan, Cheng Li, Yuhua Shi, and Min Yu, “Pharmaceutical Supply Chain in China: Current Issues and Implications for Health System Reform,” Health Policy, 97–1 (September 2010), 10.
  • Saich, Tony, op. cit., 241.
  • Ibid., 60.
  • Ibid., 242.
  • Tisdell, Clem, op.cit., 276.
  • Ibid., 276.
  • Saich, Tony, op. cit., 60.
  • Hsü, Immanuel CY, The Rise of Modern China (Sixth edition) (New York: Oxford University Press, 2000), 850.
  • Tisdell, Clem, op. cit., 278.
  • Zhou, Xue-rong, op. cit., 133.
  • Zhao, Bin, Liang Hai-lun, Zhu Ming-jun, Wang Hu-feng, “Yaopin jizhong zhaobiao caigou-jizhi zhaobiaocaigou zhuti shezhi guilu shuping—jiyu oumeng guojia butong yiliao baozhang zhidu shijian jingyan de zongjie,” [Centralized Drug Bidding System in China: Review Based on the Experience of the European Union], Chinese Pharmacy, 23–12 (2012), 1087.
  • Bao Sheng-yong, Yaofei weishenme zheme gao: dangqian woguo chengshi yaopin liutong de shehuixue fenxi [Why Are the Expenses for Drugs So High: A Sociological Analysis on the Drug Circulation of Urban China] (China: Social Sciences Academic Press, 2008), 79.
  • Bao Sheng-yong.
  • Bao Sheng-yong, op. cit., 80.
  • Xinhua News Agency, “Yisheng zipu yaopin huikou anliu,” [Doctor Discloses the Story of Kickbacks from Drugs] (April 26, 2004.), at http://www.yn.xinhuanet.com/topic/2004/sshb/wen/y11.htm (search date: April 16, 2014).
  • Bao Sheng-yong, op. cit., 83.
  • Bao Sheng-yong, op. cit., 83.
  • Pearson, Veronica, “Health and Responsibility; But Whose?,” in Linda Wong and Stewart Macpherson, eds., Social Change and Social Policy in Contemporary China (Aldershot, England: Avebury; Brookfield, Vermont USA: Ahgate, 1995), 108.
  • The World Bank, “Fixing the Public Hospital System in China,” (2010), at http://sitere-sources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1285186535266/FixingthePublicHospitalSystem.pdf (search date: April 16, 2014).
  • The World Bank, op. cit, 23.
  • Ibid., vii.
  • Wang, Guanqun, “Hospital Management Bureau Opens in Beijing, Focusing on Public Hospital Reform,” (July 28, 2011), at <http://news.xinhuanet.com/english2010/china/2011-07/28/c_131015814.htm> (search date: Accessed May 11, 2014).
  • Tian, Ying, Gu Ye, and Ni Yuanjin, “China's Health Reform Cuts Drug Prices, But Still Fights Pain,” (April 23, 2011), at <http://news.xinhuanet.com/english2010/china/2011-04/23/c_13842651.htm> (search date: May 11, 2014).
  • Ministry of Health, Zhongguo weisheng tongji nianjian erlinglingba [China Health Statistics Yearbook 2008] (China: Peking Union Medical College Press, 2008), 96.
  • Ibid., 96.
  • Ibid., 96.
  • Ibid., 96.
  • Ibid., 96.
  • Ibid., 96.
  • Ibid., 96
  • Ibid., 96
  • AARP, “AARP European Leadership Study: European Experiences with Prescription Drug Pricing,”(2006), at <http://assets.aarp.org/www.aarp.org_/cs/gap/ldrstudy_prescdrugs.pdf> (search date: May 7, 2014).
  • The World Bank, op.cit., 6.
  • Li, Mingzhi, and Kai Reimers, “Streamlining China's Pharmaceutical Distribution Channels,” in Karen Eggleston, ed., Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific (The Walter H. Shorenstein Asia-Pacific Research Center, 2009), 184.
  • Lu Zhi-lin, “Fagaiwei shiwunianlai disanshiyidao jiangyaojialing zuori luodi,” [The National Development and Reform Commission has Reduced Drug Prices for 31 Times] Yang Cheng Evening Newspaper(January 9, 2013), at http://news.sina.com.cn/o/2013-01-09/093325992361.shtml (search date: April 16, 2014).
  • Zhou, Suo-suo, “Yaojia nianjiang ershiqici shimin mei ganjue: yi jiangjia lianjiayao jiu shizong,” [Drug Prices Have Been Cut for 27 Times Within Seven Years, Citizens Had No Feelings: Cost-effective Drug Disappeared after Price was Cut] Guangzhou Daily (March 8, 2011), at <http://health.zjol.com.cn/05zjhealth/system/2011/03/08/017346568.shtml> (search date: 16 April 2014).
  • Ibid.
  • Ibid.
  • Li, Mingzhi, and Kai Reimers, op.cit., 186.
  • Ibid., 184.
  • Yu Pei-ming, li-li Song, and Shu-mei Yue, “Woguo yaopin jizhong zhaobiaocaigou cunzai de zhidu quexian,” [The Structural Flaws of the Centralized Drug Bidding System in China], China Journal of Pharmaceutical Economics, 4 (2010), 53.
  • Xinhua News, “China Issues New Rules to Curb Corruption in Government Drug Purchase,” (July 15, 2010), at <http://news.xinhuanet.com/english2010/china/2010-07/15/c_111959968.htm>(search date: 16 April 2014).
  • Ibid.
  • Yu Pei-ming, li-li Song, and Shu-mei Yue, op. cit., 53.
  • Ye, Lin, Guojia jiben yaowuzhengce yanjiu [Study on National Essential Medicine Policy in China] (China: Fudan University Press, 2009), 51.
  • Zhu, Ling-zhi, “Yigai yaopin lingjiachenghou bixu shixian duoying,” [The Zero-markup Policy on Drugs Must Bring Many Benefits] Medicine & Economics Post (August 2, 2012), at <http://news.pharmnet.com.cn/news/2012/08/02/364426.html> (search date: April 16, 2014).
  • Shan, Juan, and Qingyun Wang, “Beijing to Test Hospital Reform” Xinhua News (May 25, 2012), at <http://news.xinhuanet.com/english/china/2012-05/25/c_131609852.htm> (search date: April 25, 2014).
  • China Daily, “Many Doctors Not Content with Pay,” China Daily (August 10, 2011), at <http://www.china.org.cn/china/2011-08/10/content_23178097.htm> (search date: April 16, 2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.